argenx SE
ARGXNASDAQHealthcare● Active
$893.57
+$2.25(+0.25%)
Market Cap$55.3B
P/E Ratio—
52W High$934.62
52W Low$510.055
argenx SE (ARGX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ARGX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$5.90
Est. $6.13 · -3.8%
Revenue
$2.41B
Est. $1.45B · +66.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
ARGX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 23, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Jul 23, 2026 | $5.86 | — | — | — | $1.45B | — |
| ▼ Q2 FY2026 | May 7, 2026 | $6.13 | $5.90 | -3.8% | $2.41B | $1.45B | +66.1% |
| ▲ Q4 FY2025 | Oct 30, 2025 | $4.37 | $5.18 | +18.5% | $0.95B | $1.28B | -25.7% |
| ▲ Q2 FY2025 | May 8, 2025 | $0.98 | $2.58 | +163.3% | $1.35B | $0.86B | +56.2% |
| — Q1 FY2025 | Mar 31, 2025 | — | $2.58 | — | $0.79B | — | — |
| ▲ Q4 FY2024 | Oct 31, 2024 | $0.10 | $1.39 | +1290.0% | $0.90B | $0.67B | +35.6% |
| — Q3 FY2024 | Sep 30, 2024 | — | $1.39 | — | $0.57B | — | — |
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
$5.86
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
$5.90
EPS Est.
$6.13
EPS Surpr.
-3.8%
Revenue
$2.41B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$5.18
EPS Est.
$4.37
EPS Surpr.
+18.5%
Revenue
$0.95B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$2.58
EPS Est.
$0.98
EPS Surpr.
+163.3%
Revenue
$1.35B
Q1 FY2025
Mar 31, 2025
EPS Actual
$2.58
EPS Est.
—
EPS Surpr.
—
Revenue
$0.79B
Q4 FY2024
Oct 31, 2024Beat
EPS Actual
$1.39
EPS Est.
$0.10
EPS Surpr.
+1290.0%
Revenue
$0.90B
Q3 FY2024
Sep 30, 2024
EPS Actual
$1.39
EPS Est.
—
EPS Surpr.
—
Revenue
$0.57B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $4.21 | $5.78 | $7.02 | 13 |
| Q2 FY2026 | $5.55 | $6.70 | $7.99 | 10 |
| Q1 FY2026 | $2.57 | $5.30 | $7.01 | 11 |
| Q4 FY2025 | $2.57 | $5.16 | $7.01 | 11 |
| Q3 FY2025 | $3.35 | $4.37 | $5.88 | 12 |
| Q2 FY2025 | $3.35 | $4.37 | $5.88 | 12 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $1.2B | $1.3B | $1.4B | 20 |
| Q2 FY2026 | $1.4B | $1.6B | $1.7B | 13 |
| Q1 FY2026 | $1.1B | $1.3B | $1.4B | 14 |
| Q4 FY2025 | $1.1B | $1.3B | $1.4B | 14 |
| Q3 FY2025 | $1.0B | $1.1B | $1.1B | 15 |
| Q2 FY2025 | $1.0B | $1.1B | $1.1B | 15 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -3.8% | $807.55 | $787.31 | -2.51% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +18.5% | $821.97 | $820.36 | -0.20% |
| ▲ Q2 FY2025 | May 8, 2025 | +163.3% | $622.93 | $569.12 | -8.64% |
| — Q1 FY2025 | Mar 31, 2025 | — | $589.15 | $591.87 | +0.46% |
| ▲ Q4 FY2024 | Oct 31, 2024 | +1290.0% | $551.71 | $586.30 | +6.27% |
| — Q3 FY2024 | Sep 30, 2024 | — | $536.11 | $542.08 | +1.11% |
| ▼ Q2 FY2024 | May 9, 2024 | -46.5% | $386.08 | $382.55 | -0.91% |
| — Q1 FY2024 | Mar 31, 2024 | — | $393.72 | $397.33 | +0.92% |
Q2 FY2026-2.51%
Report Date
May 7, 2026
EPS Beat/Miss
-3.8%
Price Before
$807.55
Price After
$787.31
Q4 FY2025-0.20%
Report Date
Oct 30, 2025
EPS Beat/Miss
+18.5%
Price Before
$821.97
Price After
$820.36
Q2 FY2025-8.64%
Report Date
May 8, 2025
EPS Beat/Miss
+163.3%
Price Before
$622.93
Price After
$569.12
Q1 FY2025+0.46%
Report Date
Mar 31, 2025
EPS Beat/Miss
—
Price Before
$589.15
Price After
$591.87
Q4 FY2024+6.27%
Report Date
Oct 31, 2024
EPS Beat/Miss
+1290.0%
Price Before
$551.71
Price After
$586.30
Q3 FY2024+1.11%
Report Date
Sep 30, 2024
EPS Beat/Miss
—
Price Before
$536.11
Price After
$542.08
Q2 FY2024-0.91%
Report Date
May 9, 2024
EPS Beat/Miss
-46.5%
Price Before
$386.08
Price After
$382.55
Q1 FY2024+0.92%
Report Date
Mar 31, 2024
EPS Beat/Miss
—
Price Before
$393.72
Price After
$397.33
Avg Beat Reaction-0.86%
Avg Miss Reaction-1.71%
Beat Rate3 / 8 quarters
Largest Move-8.64% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ARGX ends December
argenx SE (ARGX) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $5.90 — missing the analyst consensus of $6.13 by -3.8%. The next ARGX earnings date is expected around September 1, 2026.
Each quarter, investors track ARGX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ARGX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ARGX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ARGX earnings · 5 questionsargenx SE's next earnings report is expected around September 1, 2026. ARGX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ARGX historically reports after market close (AMC).
ARGX earnings datewhen is ARGX earningsARGX next earnings datewhen does ARGX report earningsARGX earnings calendar
▸ Source: FMP · argenx SE SEC filings · US GAAP · argenx SE SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026